Evaluation of the Performance and Hematocrit Independence of the HemaPEN as a Volumetric Dried Blood Spot Collection Device
Deprez et al.
The finding, in our words
The HemaPEN device deposits four fixed 2.74 μL blood volumes onto paper discs and showed limited haematocrit dependence (≤7% concentration difference across a 0.20 to 0.50 haematocrit range) in 91 patient samples. This represents a marked improvement over conventional 3 mm DBS subpunches, which showed ≥25% variation, indicating the device could improve quantitative accuracy for decentralised diagnostics and screening.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
In AML and CLL, 91% of VAMS venetoclax results fell within 20% of plasma after individualised haematocrit correction; in home sampling, 18 of 21 patients self-sampled independently and 76% of returned samples were analysable, which shows home microsampling is workable, though the authors ask for multicentre validation.
Levens et al., Clinical Pharmacokinetics (paywalled) · source ↗
This review found that volumetric microsampling devices, such as Mitra, HemaPEN, HemaXis DB10, and Tasso-M20, overcome haematocrit bias, whilst Telimmune plasma separation cards enable direct plasma collection without centrifugation. These technologies support patient-centric, decentralised sampling, though the authors note that clinical validation remains limited across different drugs and patient populations.
Huhn & Scherf-Clavel, Therapeutic drug monitoring (paywalled) · source ↗
This study found that measuring thyroid-stimulating hormone via dried blood spots and a volumetric device showed high agreement with serum results, with classification accuracy exceeding 96 per cent. The volumetric approach demonstrated improved reproducibility and stability, supporting its use for decentralised thyroid function monitoring.
Bornikowska et al., Practical laboratory medicine · source ↗
The HematoCARD cartridge autonomously collects duplicate 10 microlitre dried blood spot samples from a single finger prick and shows good analytical performance for monitoring adalimumab, with accuracy between 91 and 111 per cent, linearity R squared 0.99 and coefficient of variation at or above 0.94 compared with serum reference and commercial DBS microsampling methods.
Van Hileghem et al., Analytical chemistry (paywalled) · source ↗
A 2025 review maps 28 microsampling devices, from dried spots and volumetric absorptive tips to upper-arm liquid capillary collectors, and names what a laboratory must control before their results are used: the haematocrit effect in non-volumetric dried samples, interstitial fluid from finger milking, volume, haemolysis and transport stability. Regulators on both sides of the Atlantic ask for the same two things, a device the patient can use safely and a sample fit for the test.